Dual long‑acting antibodies that lock RSV’s fusion protein from two sides protect against RSV A and B and prevent resistance, ...

Respiratory syncytial virus (RSV) can cause severe lower respiratory tract infections, particularly in newborns and older ...

Respiratory syncytial virus (RSV) has been a continuous and major cause of morbidity and mortality in babies and older people ...

We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...

In adults with chronic underlying health conditions, respiratory syncytial virus is detected more often than human metapneumovirus, especially in inpatient settings, a meta-analysis finds.

Studies show that children who suffer an RSV infection face up to 12 times higher risk of developing asthma and may be affected by long-term respiratory problems such as recurrent wheezing and ...

Thousands more people at risk from a virus which causes pneumonia and other serious lung infections will be able to get vital protection on the NHS this winter. From September, all adults aged 65-74 ...

Flu season is no longer just flu season. Since 2022, the health care community has faced what's known as a "tripledemic" of ...

A study of women in 8 countries finds that they often agree to RSV vaccination during pregnancy and believe it’s better than ...

The RSV vaccination programme will be extended to all adults aged 65-74 who are living with a chronic respiratory condition ...

The NHS has confirmed that from September 1, adults aged 65 to 74 with certain health conditions will become eligible for the ...